Identification of Novel, Therapy-Responsive Protein Biomarkers in a Mouse Model of Duchenne Muscular Dystrophy by Aptamer-Based Serum Proteomics

Scientific Reports- United Kingdom

doi 10.1038/srep17014

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Therapy of Genetic Disorders: Novel Therapies for Duchenne Muscular Dystrophy

Current Pediatrics Reports
2014English

Improved Mouse Model for Studying Duchenne Muscular Dystrophy (DMD)

Science-Business eXchange
2010Danish

Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the MDX Mouse Model of Duchenne Muscular Dystrophy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Progress Toward Gene Therapy of Duchenne Muscular Dystrophy

Seminars in Neurology
Neurology
1999English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy Gene Therapy: Lost in Translation?

Research and Reports in Biology
2011English

Duchenne Muscular Dystrophy

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy